Showing results (481-490 of 3,788) with videos related to
Sort By:
Pageof 379
Oncoimmunology|July 30, 2013
Trial watch: Oncolytic viruses for cancer therapyErika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, et al.Oncoimmunology|March 5, 2016
T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastomaNathan Singh, Irina Kulikovskaya, David M Barrett, et al.Oncoimmunology|March 5, 2016
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccinationKalijn F Bol, Erik H J G Aarntzen, Florentien E M In 't Hout, et al.Oncoimmunology|March 5, 2016
Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosisH Bonsang-Kitzis, B Sadacca, A S Hamy-Petit, et al.Oncoimmunology|March 5, 2016
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and miceKirsten D Mertz, Lukas F Mager, Marie-Hélène Wasmer, et al.Oncoimmunology|March 5, 2016
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responsesYusuf Dölen, Martin Kreutz, Uzi Gileadi, et al.Oncoimmunology|March 5, 2016
Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment-Evidence to turn on the LIGHTAjay V MakerOncoimmunology|March 5, 2016
CorrigendumOncoimmunology|November 20, 2013
Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccinationAdam J Litterman, Arkadiusz Z Dudek, David A LargaespadaOncoimmunology|November 20, 2013
Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responsesBrian A BaldoPageof 379